Keyphrases
Activin Type II Receptor
11%
ALK1
11%
ALK3
11%
ALK6
22%
Anchorage-independent Growth
11%
Anoikis
100%
Antimetastatic
11%
BMP9
11%
BMPR2
11%
Bone Morphogenetic Protein
11%
Breast Cancer
11%
Breast Epithelium
100%
Cancer Cell Lines
11%
Cell Death Pathways
11%
Cell Fate Decision
11%
Cell Matrix
11%
Clinical Trials
11%
Complex Formation
11%
Differentiation Factors
100%
Epigenetic Drugs
11%
Epigenetic Regulation
100%
Epigenetic Silencing
11%
Epithelial Cells
11%
GDF2
11%
Growth Factor Pathway
11%
Growth Factors
100%
Growth Regulation
100%
In Cancer
11%
Line Data
11%
Metastasis
11%
Oncogenesis
22%
Ovarian Cancer
11%
Patient Data
11%
Promoter Methylation
22%
Protein Family
11%
Serine-threonine Kinase
22%
Signaling Axis
11%
Smad1
33%
Smad2
11%
Transforming Growth Factor-β
22%
Type I Receptor
11%
Biochemistry, Genetics and Molecular Biology
Activin Receptor
25%
Anchorage Independent Growth
25%
Anoikis
100%
Bone Morphogenetic Protein
25%
Cancer Cell
25%
Carcinogenesis
50%
Cell Death
25%
Cell Fate
25%
Clinical Trial
25%
Complex Formation
25%
Downregulation
25%
Eicosanoid Receptor
50%
Epigenetics
100%
GDF2
25%
Kinase
50%
Methylation
50%
Patient Coding
25%
Phosphotransferase
50%
Promoter Region
50%
Protein Family
25%
Serine
50%
Threonine
50%
Transforming Growth Factor
50%
Medicine and Dentistry
Anchorage Independent Growth
9%
Anoikis
100%
Bone Morphogenetic Protein
9%
Bone Morphogenetic Protein 9
100%
Bone Morphogenetic Protein Receptor 1A
9%
Breast Cancer
9%
Breast Epithelium
100%
Cancer Cell Line
9%
Carcinogenesis
18%
Cell Death
9%
Cell Fate
9%
Cell Line
9%
Clinical Trial
9%
Complex Formation
9%
Downregulation
9%
Epithelial Cell
9%
Extracellular Matrix
9%
Metastatic Carcinoma
9%
Methylation
18%
Ovarian Cancer
9%
Patient-Data
9%
Promoter Region
18%
Protein Family
9%
Protein Serine Threonine Kinase
18%
Receptor
18%
Transforming Growth Factor
18%
Immunology and Microbiology
Anchorage Independent Growth
9%
Anoikis
100%
Bone Morphogenetic Protein
9%
Bone Morphogenetic Protein 9
100%
Bone Morphogenetic Protein Receptor 1A
9%
Breast Epithelium
100%
Cancer Cell Line
9%
Cell Death
9%
Cell Fate
9%
Cell Line
9%
Complex Formation
9%
Downregulation
9%
Epigenetics
100%
Extracellular Matrix
9%
Methylation
18%
Patient Coding
9%
Promoter Region
18%
Protein Family
9%
Transforming Growth Factor
18%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Morphogenetic Protein
9%
Bone Morphogenetic Protein 9
100%
Bone Morphogenetic Protein Receptor 1A
9%
Breast Cancer
9%
Carcinogenesis
18%
Clinical Trial
9%
Malignant Neoplasm
9%
Ovary Cancer
9%
Protein Serine Threonine Kinase
18%
Receptor
18%
Transforming Growth Factor
18%